BCL2 and neoplasm: For example, treatment of mice bearing H146 lung cancer xenografts with the Bcl-2 inhibitor ABT-737 leads to transient increases in circulating CK18 and cleaved caspase levels that correlate with treatment and tumour burden (Micha et al, 2008).